Weila Wang

Weila Wang, MD, PhD, is an experienced professional in regulatory affairs, currently serving as Senior Director of Regulatory Affairs at CureVac since March 2021. Previously, Weila held key positions in several prominent organizations, including Senior Director of Global Regulatory Science Biologics at Mylan and Director of Global Regulatory Affairs at GSK. Weila's extensive experience encompasses roles such as Global Regulatory Lead for biosimilar programs, Senior Manager of Regulatory Affairs at Emergent BioSolutions, and Regulatory Affairs Manager at PPD. Early career experience includes serving as a Staff Fellow/Reviewer at the FDA, specializing in biologic marketing applications and IND application reviews, as well as conducting research at the American Red Cross. Weila Wang's educational background includes a Ph.D. in Immunology from Hokkaido University and a Master's degree in Medicine and an M.D. from Jiangxi College of Chinese Medicine.